Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation 5 June 2020
Agreement during the Q 1 2020 National Consultation and Planning for the National TB Control Program held at Angeles City and Iloilo City on February 17-19 and March 9-11. 7 May 2020
Designation of Selected Regional TB Culture Laboratories for GeneXpert Diagnosis of Coronavirus Disease 2019 (COVID-19) 21 April 2020
Guidelines for Culture Laboratories on the Conduct of Mycobacteriological Tests under the Programmatic Management of Drug-resistant Tuberculosis 8 April 2020
Reiteration of Policy on the Implementation of Active TB drug-safety monitoring and management (aDSM) 18 March 2020
Guidelines on the Use of Xpert MTB/RIF as Primary Diagnostic test for All Presumptive TB 28 February 2020
Conduct of Assessment of Clinical Diagnosis of Tuberculosis and Support Needed from Concerned Agencies 24 February 2020